Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Sunday, March 3, 2013 - 11:32am
tags:
AbbVie, GLPG0634, BT-061, rheumatoid arthritis, psoriasis
Eli Lilly Sues Genentech Seeking to Invalidate Cabilly Patents
Bloomberg
Sunday, March 3, 2013 - 11:30am
tags:
Eli Lilly, Genentech, Erbitux, patents, Patent Infringement, lawsuits
This Week in Biotech
Motley Fool
Sunday, March 3, 2013 - 11:27am
tags:
Dynavax, Zogenix, Optimer Pharmaceuticals, Affymax, Vivus
Salix Pharmaceuticals Price Target Raised to $53.00 at Brean Murray (SLXP)
Jags Report
Sunday, March 3, 2013 - 11:26am
tags:
Salix
US FDA accepts Sunovion's resubmitted NDA for Stedesa for review
Pharmabiz
Sunday, March 3, 2013 - 11:25am
tags:
Sunovion, epilepsy, Stedesa
Cerus Beats on Both Top and Bottom Lines
Motley Fool
Sunday, March 3, 2013 - 11:23am
tags:
Cerus, earnings
A Drug That's Ready to Lose
Motley Fool
Sunday, March 3, 2013 - 11:23am
tags:
Belviq, Arena Pharmaceuticals, obesity, weight loss
Celgene drug shown to be effective, safe in psoriasis trial
Reuters
Sunday, March 3, 2013 - 11:22am
tags:
Cellgene, psoriasis, apremilast
Medivation Earnings Call Nuggets: Gross to Net Conversion and the Pre-Chemo Market
Wall Street Cheat Street
Sunday, March 3, 2013 - 11:20am
tags:
Medivation, earnings
Are Short Sellers Right About Spectrum?
Motley Fool
Sunday, March 3, 2013 - 11:19am
tags:
Spectrum Pharmaceuticals
3 Bio-Pharmaceuticals Insiders Love
Motley Fool
Sunday, March 3, 2013 - 11:19am
tags:
MannKind, Merrimack Pharmaceuticals, Tesaro
Cellceutix - A Biotech To Consider For 2013
Seeking Alpha
Sunday, March 3, 2013 - 11:18am
tags:
Cellceutix
Who's the Frailest Big Pharma of All?
Motley Fool
Saturday, March 2, 2013 - 4:08pm
tags:
Bristol-Myers Squibb, AstraZeneca, Pfizer, Eli Lilly, Sanofi
Vertex Enters Critical Phase (video)
Motley Fool
Saturday, March 2, 2013 - 4:04pm
tags:
Vertex Pharmaceuticals
Mylan Just Got More Interesting
Motley Fool
Saturday, March 2, 2013 - 4:03pm
tags:
Mylan
KYTHERA Biopharmaceuticals, Inc. to Present New Data at 2013 American Academy of Dermatology (AAD) Annual Meeting Demonstrating Results for ATX-101 in the Reduction of Submental Fat (SMF) or “Double Chin”
Yahoo/BusinessWire
Saturday, March 2, 2013 - 4:03pm
tags:
ATX-101, obesity, weight loss, Kythera Biopharmaceuticals
Assessing The Dividend Growth Potential For The New Abbott
Seeking Alpha
Saturday, March 2, 2013 - 4:01pm
tags:
Abbott Laboratories
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Saturday, March 2, 2013 - 4:00pm
tags:
pancreatitis, diabetes, type 2 diabetes, Merck, AstraZeneca, Bristol-Myers Squibb
PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, March 2, 2013 - 3:57pm
tags:
PDL Biopharma, earnings
1 Overblown Biotech Selloff
Motley Fool
Saturday, March 2, 2013 - 3:57pm
tags:
Medivation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.